Search Results - Yuksel Urun

Refine Results
  1. 1

    Adjuvant Treatment in Non-Small Cell Lung Cancer by Mustafa Gürbüz, Yüksel Ürün

    Get full text
    Article


  2. 2

    Unveiling the Role of Human Papillomavirus in Urogenital Carcinogenesis a Comprehensive Review by Beliz Bahar Karaoğlan, Yüksel Ürün

    Published in Viruses (2024-04-01)
    Get full text
    Article


  3. 3

    Classical Kaposi sarcoma: an ınsight into demographic characteristics and survival outcomes by Engin Eren Kavak, Yüksel Ürün

    Published in BMC Cancer (2025-04-01)
    Get full text
    Article


  4. 4

    Effects of Adjuvant Chemotherapy on Insulin Resistance in Patients with Early Breast Cancer by Izzet Doğan, Yüksel Ürün, Handan Onur

    Published in Cam & Sakura Medical Journal (2022-04-01)
    Get full text
    Article


  5. 5

    Emerging Strategies in Adjuvant Immunotherapy: A Comparative Review of Bladder Cancer and Renal Cell Carcinoma Treatments by Sevinc Balli, Hatice Bolek, Yüksel Ürün

    Published in Clinical Medicine Insights: Oncology (2024-05-01)
    Get full text
    Article


  6. 6

    Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same? by Emre Yekedüz, Güngör Utkan, Ravindran Kanesvaran, Yüksel Ürün

    Published in Prostate International (2021-03-01)
    Get full text
    Article


  7. 7

    The prognostic value of elimination rate constant K score of prostate-specific antigen in metastatic castration-resistant prostate cancer patients treated with docetaxel by Satı Coşkun Yazgan, Abdulkadir Sarı, Hatice Bölek, Emre Yekedüz, Yüksel Ürün

    Published in Prostate International (2025-06-01)
    Get full text
    Article


  8. 8

    Primary Prostatic Stromal Sarcoma: A Case Report and Review of the Literature by Enes Erul, Ömer Gülpınar, Diğdem Kuru Öz, Havva Berber, Saba Kiremitci, Yüksel Ürün

    Published in Medicina (2024-11-01)
    Get full text
    Article


  9. 9

    Perceptions and Expectations: A Study on Prognostic Perception and Quality of Life in Patients With Metastatic Renal and Bladder Cancer by Hatice Bolek, Cagatay Arslan, Mert Basaran, İrfan Cicin, Mustafa Ozguroglu, Deniz Tural, Yüksel Ürün

    Published in JCO Global Oncology (2024-08-01)
    Get full text
    Article


  10. 10

    Management of metastatic castration-resistant prostate cancer in Middle East African countries: Challenges and strategic recommendations by Shouki Bazarbashi, Abdullah Alsharm, Alaa Meshref, Hind Mrabti, Jawaher Ansari, Marwan Ghosn, Mohamed Abdulla, Yuksel Urun

    Published in Urology Annals (2022-01-01)
    Get full text
    Article


  11. 11

    Risk factors for thrombosis risk in patients with cancer by Dilara Turan, Hatime Arzu Yasar, Ozge Bas Aksu, Elif Berna Koksoy, Gungor Utkan, Hakan Akbulut, Yuksel Urun

    Published in Journal of Oncological Sciences (2018-12-01)
    Get full text
    Article


  12. 12

    Clinical predictive factors associated with pathologic complete response in locally advanced rectal cancer by Yakup Bozkaya, Nuriye Yıldırım Özdemir, Gökmen Umut Erdem, Ebru Karcı Güner, Yüksel Ürün, Nebi Serkan Demirci, Ozan Yazıcı, Osman Köstek, Nurullah Zengin

    Published in Journal of Oncological Sciences (2018-04-01)
    Get full text
    Article


  13. 13

    Perceptions, Attitudes, and Concerns on Artificial Intelligence Applications in Patients with Cancer by Enes Erul MD, Yusuf Aktekin MD, Furkan Berk Danışman BSc, Şükrü Armanç Gümüştaş, Büşra Saraç Aktekin MD, Emre Yekedüz MD, Yüksel Ürün MD

    Published in Cancer Control (2025-05-01)
    Get full text
    Article


  14. 14

    Navigating second-line therapy in metastatic renal cell carcinoma: a comparative analysis of immune checkpoint inhibitors and tyrosine kinase inhibitors: a study of Turkish Oncolog... by Musa Barış Aykan, Hatice Bölek, Emre Yekedüz, Elif Sertesen, Deniz Tural, Cengiz Karaçin, Mehmet Ali Nahit Şendur, Gökhan Uçar, Çağatay Arslan, Selver Işık, Saadet Sim, Özlem Nuray Sever, Bekir Hacıoğlu, Sema Sezgin Göksu, Mustafa Özgüroğlu, Nuri Karadurmuş, Yüksel Ürün

    Published in Therapeutic Advances in Medical Oncology (2025-04-01)
    Get full text
    Article


  15. 15

    Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study by Sabin Goktas Aydin, Engin Eren Kavak, Atakan Topcu, Ayberk Bayramgil, Fahri Akgul, Seda Kahraman, Musa Baris Aykan, Yunus Emre Altıntas, Kaan Helvaci, Yuksel Urun, Ahmet Bilici, Mesut Seker, Mehmet Ali Nahit Sendur, Omer Fatih Olmez, Ozgur Acikgoz, Irfan Cicin

    Published in Biomolecules & Biomedicine (2023-11-01)
    Get full text
    Article


  16. 16

    The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study by Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kilickap

    Published in Cancer Medicine (2024-01-01)
    Get full text
    Article


  17. 17

    Sunitinib in metastatic renal cell carcinoma: clinical outcomes across risk groups in a Turkish Oncology Group Kidney Cancer Consortium by Hatice Bolek, Omer Faruk Kuzu, Elif Sertesen Camoz, Saadet Sim, Serhat Sekmek, Hilal Karakas, Selver Isık, Murad Guliyev, Aysun Fatma Akkus, Deniz Tural, Cagatay Arslan, Sema Sezin Goksu, Ozlem Nuray Sever, Nuri Karadurmus, Cengiz Karacin, Mehmet Ali Nahit Sendur, Emre Yekedüz, Yuksel Urun

    Published in Cancer Communications (2025-05-01)
    Get full text
    Article


  18. 18

    Impact of first-line tyrosine kinase inhibitor selection on survival outcomes with second-line nivolumab in metastatic renal cell carcinoma by Omer Faruk Kuzu, Hatice Bolek, Elif Sertesen Camoz, Hilal Karakas, Serhat Sekmek, Saadet Sim, Selver Isık, Murat Günaltılı, Aysun Fatma Akkus, Deniz Tural, Cagatay Arslan, Sema Sezin Goksu, Ozlem Nuray Sever, Cengiz Karacin, Mehmet Ali Nahit Sendur, Nuri Karadurmus, Emre Yekedüz, Yüksel Ürün

    Published in BMC Cancer (2025-07-01)
    Get full text
    Article


  19. 19

    The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors by Kadriye Bir Yücel, Emre Yekedüz, Serdar Karakaya, Deniz Tural, İsmail Ertürk, Cihan Erol, Özlem Ercelep, Nihan Şentürk Öztaş, Çağatay Arslan, Gökhan Uçar, Ahmet Küçükarda, Özlem Nuray Sever, Saadettin Kılıçkap, Orçun Can, Satı Coşkun Yazgan, Berna Öksüzoğlu, Nuri Karadurmuş, Mehmet Ali Şendur, Yüksel Ürün

    Published in Scientific Reports (2022-10-01)
    Get full text
    Article


  20. 20

    Real‐Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON‐2 Retrospective Experience by Mimma Rizzo, Franco Morelli, Yüksel Ürün, Sebastiano Buti, Se Hoon Park, Maria T. Bourlon, Enrique Grande, Francesco Massari, Johannes Landmesser, Alexandr Poprach, Hideki Takeshita, Giandomenico Roviello, Zin W. Myint, Lazar Popovic, Andrey Soares, Halima Abahssain, Patrizia Giannatempo, Javier Molina‐Cerrillo, Lorena Incorvaia, Samer Salah, Annalisa Zeppellini, Fernando Sabino Marques Monteiro, Camillo Porta, Shilpa Gupta, Matteo Santoni

    Published in Cancer Medicine (2025-02-01)
    Get full text
    Article


Search Tools: